Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1480499

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1480499

Rat Model

PUBLISHED:
PAGES: 158 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Global Rat Model Market to Reach $2.5 Billion by 2030

The global market for Rat Model estimated at US$1.6 Billion in the year 2023, is expected to reach US$2.5 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2023-2030. Inbred Rat Model, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$825.8 Million by the end of the analysis period. Growth in the Outbred Rat Model segment is estimated at 7.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $474.7 Million, While China is Forecast to Grow at 6.6% CAGR

The Rat Model market in the U.S. is estimated at US$474.7 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$439.9 Million by the year 2030 trailing a CAGR of 6.6% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.8% and 5.4% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 5% CAGR.

Introducing Our Exciting New Report Features for 2024

Full access to influencer engagement stats

Free access to our digital archives & "MarketGlass" research platform. Our proprietary MarketGlass platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. Our state-of-art tools bring world class market perspectives while protecting participants' privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.

Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities

Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas

Complimentary report updates for one year

Competitor coverage with global market shares of major players

Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies

Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024

Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 12 Featured) -

  • Biomere
  • Charles River Laboratories International, Inc.
  • Covance, Inc.
  • Envigo, Inc.
  • Genoway S.A.
  • Horizon Discovery Group PLC
  • Janvier Labs
  • Taconic Biosciences, Inc.
  • Transposagen Biopharmaceuticals, Inc.
  • Transviragen, Inc.
Product Code: MCP14356

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Rat Model - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Rat Model Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Rat Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Rat Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Rat Model by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Inbred by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Inbred by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Inbred by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Outbred by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Outbred by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Outbred by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Knockout by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Knockout by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Knockout by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hybrid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hybrid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hybrid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Rat Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Rat Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other Rat Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for CRISPR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for CRISPR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for CRISPR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Microinjection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Microinjection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Microinjection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Nuclear Transfer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Nuclear Transfer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Nuclear Transfer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Embryonic Stem Cell Injection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Embryonic Stem Cell Injection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Embryonic Stem Cell Injection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Research & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Research & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Research & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Production & Quality Control by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Production & Quality Control by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: World 16-Year Perspective for Production & Quality Control by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Academics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Academics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: World 16-Year Perspective for Academics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Human by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Human by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: World 16-Year Perspective for Human by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 50: World Recent Past, Current & Future Analysis for Veterinary by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 51: World Historic Review for Veterinary by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: World 16-Year Perspective for Veterinary by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Rat Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 53: USA Recent Past, Current & Future Analysis for Rat Model by End-Use - Human and Veterinary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Rat Model by End-Use - Human and Veterinary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: USA 16-Year Perspective for Rat Model by End-Use - Percentage Breakdown of Value Sales for Human and Veterinary for the Years 2014, 2024 & 2030
    • TABLE 56: USA Recent Past, Current & Future Analysis for Rat Model by Rat Type - Inbred, Outbred, Knockout, Hybrid and Other Rat Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: USA Historic Review for Rat Model by Rat Type - Inbred, Outbred, Knockout, Hybrid and Other Rat Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: USA 16-Year Perspective for Rat Model by Rat Type - Percentage Breakdown of Value Sales for Inbred, Outbred, Knockout, Hybrid and Other Rat Types for the Years 2014, 2024 & 2030
    • TABLE 59: USA Recent Past, Current & Future Analysis for Rat Model by Technology - CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: USA Historic Review for Rat Model by Technology - CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: USA 16-Year Perspective for Rat Model by Technology - Percentage Breakdown of Value Sales for CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 62: USA Recent Past, Current & Future Analysis for Rat Model by Application - Research & Development , Production & Quality Control, Academics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: USA Historic Review for Rat Model by Application - Research & Development , Production & Quality Control, Academics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: USA 16-Year Perspective for Rat Model by Application - Percentage Breakdown of Value Sales for Research & Development , Production & Quality Control, Academics and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 65: Canada Recent Past, Current & Future Analysis for Rat Model by End-Use - Human and Veterinary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for Rat Model by End-Use - Human and Veterinary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Canada 16-Year Perspective for Rat Model by End-Use - Percentage Breakdown of Value Sales for Human and Veterinary for the Years 2014, 2024 & 2030
    • TABLE 68: Canada Recent Past, Current & Future Analysis for Rat Model by Rat Type - Inbred, Outbred, Knockout, Hybrid and Other Rat Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Canada Historic Review for Rat Model by Rat Type - Inbred, Outbred, Knockout, Hybrid and Other Rat Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Canada 16-Year Perspective for Rat Model by Rat Type - Percentage Breakdown of Value Sales for Inbred, Outbred, Knockout, Hybrid and Other Rat Types for the Years 2014, 2024 & 2030
    • TABLE 71: Canada Recent Past, Current & Future Analysis for Rat Model by Technology - CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Canada Historic Review for Rat Model by Technology - CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Canada 16-Year Perspective for Rat Model by Technology - Percentage Breakdown of Value Sales for CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 74: Canada Recent Past, Current & Future Analysis for Rat Model by Application - Research & Development , Production & Quality Control, Academics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Canada Historic Review for Rat Model by Application - Research & Development , Production & Quality Control, Academics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Canada 16-Year Perspective for Rat Model by Application - Percentage Breakdown of Value Sales for Research & Development , Production & Quality Control, Academics and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • Rat Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 77: Japan Recent Past, Current & Future Analysis for Rat Model by End-Use - Human and Veterinary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Japan Historic Review for Rat Model by End-Use - Human and Veterinary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Japan 16-Year Perspective for Rat Model by End-Use - Percentage Breakdown of Value Sales for Human and Veterinary for the Years 2014, 2024 & 2030
    • TABLE 80: Japan Recent Past, Current & Future Analysis for Rat Model by Rat Type - Inbred, Outbred, Knockout, Hybrid and Other Rat Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Japan Historic Review for Rat Model by Rat Type - Inbred, Outbred, Knockout, Hybrid and Other Rat Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Japan 16-Year Perspective for Rat Model by Rat Type - Percentage Breakdown of Value Sales for Inbred, Outbred, Knockout, Hybrid and Other Rat Types for the Years 2014, 2024 & 2030
    • TABLE 83: Japan Recent Past, Current & Future Analysis for Rat Model by Technology - CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Japan Historic Review for Rat Model by Technology - CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Japan 16-Year Perspective for Rat Model by Technology - Percentage Breakdown of Value Sales for CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 86: Japan Recent Past, Current & Future Analysis for Rat Model by Application - Research & Development , Production & Quality Control, Academics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Japan Historic Review for Rat Model by Application - Research & Development , Production & Quality Control, Academics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Japan 16-Year Perspective for Rat Model by Application - Percentage Breakdown of Value Sales for Research & Development , Production & Quality Control, Academics and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • Rat Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 89: China Recent Past, Current & Future Analysis for Rat Model by End-Use - Human and Veterinary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: China Historic Review for Rat Model by End-Use - Human and Veterinary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: China 16-Year Perspective for Rat Model by End-Use - Percentage Breakdown of Value Sales for Human and Veterinary for the Years 2014, 2024 & 2030
    • TABLE 92: China Recent Past, Current & Future Analysis for Rat Model by Rat Type - Inbred, Outbred, Knockout, Hybrid and Other Rat Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: China Historic Review for Rat Model by Rat Type - Inbred, Outbred, Knockout, Hybrid and Other Rat Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: China 16-Year Perspective for Rat Model by Rat Type - Percentage Breakdown of Value Sales for Inbred, Outbred, Knockout, Hybrid and Other Rat Types for the Years 2014, 2024 & 2030
    • TABLE 95: China Recent Past, Current & Future Analysis for Rat Model by Technology - CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: China Historic Review for Rat Model by Technology - CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: China 16-Year Perspective for Rat Model by Technology - Percentage Breakdown of Value Sales for CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 98: China Recent Past, Current & Future Analysis for Rat Model by Application - Research & Development , Production & Quality Control, Academics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: China Historic Review for Rat Model by Application - Research & Development , Production & Quality Control, Academics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: China 16-Year Perspective for Rat Model by Application - Percentage Breakdown of Value Sales for Research & Development , Production & Quality Control, Academics and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • Rat Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 101: Europe Recent Past, Current & Future Analysis for Rat Model by End-Use - Human and Veterinary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for Rat Model by End-Use - Human and Veterinary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Europe 16-Year Perspective for Rat Model by End-Use - Percentage Breakdown of Value Sales for Human and Veterinary for the Years 2014, 2024 & 2030
    • TABLE 104: Europe Recent Past, Current & Future Analysis for Rat Model by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 105: Europe Historic Review for Rat Model by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Europe 16-Year Perspective for Rat Model by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 107: Europe Recent Past, Current & Future Analysis for Rat Model by Rat Type - Inbred, Outbred, Knockout, Hybrid and Other Rat Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Europe Historic Review for Rat Model by Rat Type - Inbred, Outbred, Knockout, Hybrid and Other Rat Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Europe 16-Year Perspective for Rat Model by Rat Type - Percentage Breakdown of Value Sales for Inbred, Outbred, Knockout, Hybrid and Other Rat Types for the Years 2014, 2024 & 2030
    • TABLE 110: Europe Recent Past, Current & Future Analysis for Rat Model by Technology - CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Europe Historic Review for Rat Model by Technology - CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Europe 16-Year Perspective for Rat Model by Technology - Percentage Breakdown of Value Sales for CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 113: Europe Recent Past, Current & Future Analysis for Rat Model by Application - Research & Development , Production & Quality Control, Academics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Europe Historic Review for Rat Model by Application - Research & Development , Production & Quality Control, Academics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Europe 16-Year Perspective for Rat Model by Application - Percentage Breakdown of Value Sales for Research & Development , Production & Quality Control, Academics and Other Applications for the Years 2014, 2024 & 2030
  • FRANCE
    • Rat Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 116: France Recent Past, Current & Future Analysis for Rat Model by End-Use - Human and Veterinary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: France Historic Review for Rat Model by End-Use - Human and Veterinary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: France 16-Year Perspective for Rat Model by End-Use - Percentage Breakdown of Value Sales for Human and Veterinary for the Years 2014, 2024 & 2030
    • TABLE 119: France Recent Past, Current & Future Analysis for Rat Model by Rat Type - Inbred, Outbred, Knockout, Hybrid and Other Rat Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: France Historic Review for Rat Model by Rat Type - Inbred, Outbred, Knockout, Hybrid and Other Rat Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: France 16-Year Perspective for Rat Model by Rat Type - Percentage Breakdown of Value Sales for Inbred, Outbred, Knockout, Hybrid and Other Rat Types for the Years 2014, 2024 & 2030
    • TABLE 122: France Recent Past, Current & Future Analysis for Rat Model by Technology - CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: France Historic Review for Rat Model by Technology - CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: France 16-Year Perspective for Rat Model by Technology - Percentage Breakdown of Value Sales for CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 125: France Recent Past, Current & Future Analysis for Rat Model by Application - Research & Development , Production & Quality Control, Academics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: France Historic Review for Rat Model by Application - Research & Development , Production & Quality Control, Academics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: France 16-Year Perspective for Rat Model by Application - Percentage Breakdown of Value Sales for Research & Development , Production & Quality Control, Academics and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Rat Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 128: Germany Recent Past, Current & Future Analysis for Rat Model by End-Use - Human and Veterinary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Germany Historic Review for Rat Model by End-Use - Human and Veterinary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Germany 16-Year Perspective for Rat Model by End-Use - Percentage Breakdown of Value Sales for Human and Veterinary for the Years 2014, 2024 & 2030
    • TABLE 131: Germany Recent Past, Current & Future Analysis for Rat Model by Rat Type - Inbred, Outbred, Knockout, Hybrid and Other Rat Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Germany Historic Review for Rat Model by Rat Type - Inbred, Outbred, Knockout, Hybrid and Other Rat Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Germany 16-Year Perspective for Rat Model by Rat Type - Percentage Breakdown of Value Sales for Inbred, Outbred, Knockout, Hybrid and Other Rat Types for the Years 2014, 2024 & 2030
    • TABLE 134: Germany Recent Past, Current & Future Analysis for Rat Model by Technology - CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Germany Historic Review for Rat Model by Technology - CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Germany 16-Year Perspective for Rat Model by Technology - Percentage Breakdown of Value Sales for CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 137: Germany Recent Past, Current & Future Analysis for Rat Model by Application - Research & Development , Production & Quality Control, Academics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Germany Historic Review for Rat Model by Application - Research & Development , Production & Quality Control, Academics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Germany 16-Year Perspective for Rat Model by Application - Percentage Breakdown of Value Sales for Research & Development , Production & Quality Control, Academics and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 140: Italy Recent Past, Current & Future Analysis for Rat Model by End-Use - Human and Veterinary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Italy Historic Review for Rat Model by End-Use - Human and Veterinary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Italy 16-Year Perspective for Rat Model by End-Use - Percentage Breakdown of Value Sales for Human and Veterinary for the Years 2014, 2024 & 2030
    • TABLE 143: Italy Recent Past, Current & Future Analysis for Rat Model by Rat Type - Inbred, Outbred, Knockout, Hybrid and Other Rat Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Italy Historic Review for Rat Model by Rat Type - Inbred, Outbred, Knockout, Hybrid and Other Rat Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Italy 16-Year Perspective for Rat Model by Rat Type - Percentage Breakdown of Value Sales for Inbred, Outbred, Knockout, Hybrid and Other Rat Types for the Years 2014, 2024 & 2030
    • TABLE 146: Italy Recent Past, Current & Future Analysis for Rat Model by Technology - CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Italy Historic Review for Rat Model by Technology - CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Italy 16-Year Perspective for Rat Model by Technology - Percentage Breakdown of Value Sales for CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 149: Italy Recent Past, Current & Future Analysis for Rat Model by Application - Research & Development , Production & Quality Control, Academics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Italy Historic Review for Rat Model by Application - Research & Development , Production & Quality Control, Academics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Italy 16-Year Perspective for Rat Model by Application - Percentage Breakdown of Value Sales for Research & Development , Production & Quality Control, Academics and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Rat Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 152: UK Recent Past, Current & Future Analysis for Rat Model by End-Use - Human and Veterinary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: UK Historic Review for Rat Model by End-Use - Human and Veterinary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: UK 16-Year Perspective for Rat Model by End-Use - Percentage Breakdown of Value Sales for Human and Veterinary for the Years 2014, 2024 & 2030
    • TABLE 155: UK Recent Past, Current & Future Analysis for Rat Model by Rat Type - Inbred, Outbred, Knockout, Hybrid and Other Rat Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: UK Historic Review for Rat Model by Rat Type - Inbred, Outbred, Knockout, Hybrid and Other Rat Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: UK 16-Year Perspective for Rat Model by Rat Type - Percentage Breakdown of Value Sales for Inbred, Outbred, Knockout, Hybrid and Other Rat Types for the Years 2014, 2024 & 2030
    • TABLE 158: UK Recent Past, Current & Future Analysis for Rat Model by Technology - CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: UK Historic Review for Rat Model by Technology - CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: UK 16-Year Perspective for Rat Model by Technology - Percentage Breakdown of Value Sales for CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 161: UK Recent Past, Current & Future Analysis for Rat Model by Application - Research & Development , Production & Quality Control, Academics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: UK Historic Review for Rat Model by Application - Research & Development , Production & Quality Control, Academics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: UK 16-Year Perspective for Rat Model by Application - Percentage Breakdown of Value Sales for Research & Development , Production & Quality Control, Academics and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 164: Rest of Europe Recent Past, Current & Future Analysis for Rat Model by End-Use - Human and Veterinary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Europe Historic Review for Rat Model by End-Use - Human and Veterinary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Rest of Europe 16-Year Perspective for Rat Model by End-Use - Percentage Breakdown of Value Sales for Human and Veterinary for the Years 2014, 2024 & 2030
    • TABLE 167: Rest of Europe Recent Past, Current & Future Analysis for Rat Model by Rat Type - Inbred, Outbred, Knockout, Hybrid and Other Rat Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Rest of Europe Historic Review for Rat Model by Rat Type - Inbred, Outbred, Knockout, Hybrid and Other Rat Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Rest of Europe 16-Year Perspective for Rat Model by Rat Type - Percentage Breakdown of Value Sales for Inbred, Outbred, Knockout, Hybrid and Other Rat Types for the Years 2014, 2024 & 2030
    • TABLE 170: Rest of Europe Recent Past, Current & Future Analysis for Rat Model by Technology - CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Rest of Europe Historic Review for Rat Model by Technology - CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Rest of Europe 16-Year Perspective for Rat Model by Technology - Percentage Breakdown of Value Sales for CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Rat Model by Application - Research & Development , Production & Quality Control, Academics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Rest of Europe Historic Review for Rat Model by Application - Research & Development , Production & Quality Control, Academics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Rest of Europe 16-Year Perspective for Rat Model by Application - Percentage Breakdown of Value Sales for Research & Development , Production & Quality Control, Academics and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Rat Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 176: Asia-Pacific Recent Past, Current & Future Analysis for Rat Model by End-Use - Human and Veterinary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Asia-Pacific Historic Review for Rat Model by End-Use - Human and Veterinary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Asia-Pacific 16-Year Perspective for Rat Model by End-Use - Percentage Breakdown of Value Sales for Human and Veterinary for the Years 2014, 2024 & 2030
    • TABLE 179: Asia-Pacific Recent Past, Current & Future Analysis for Rat Model by Rat Type - Inbred, Outbred, Knockout, Hybrid and Other Rat Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Asia-Pacific Historic Review for Rat Model by Rat Type - Inbred, Outbred, Knockout, Hybrid and Other Rat Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Asia-Pacific 16-Year Perspective for Rat Model by Rat Type - Percentage Breakdown of Value Sales for Inbred, Outbred, Knockout, Hybrid and Other Rat Types for the Years 2014, 2024 & 2030
    • TABLE 182: Asia-Pacific Recent Past, Current & Future Analysis for Rat Model by Technology - CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Asia-Pacific Historic Review for Rat Model by Technology - CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Asia-Pacific 16-Year Perspective for Rat Model by Technology - Percentage Breakdown of Value Sales for CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Rat Model by Application - Research & Development , Production & Quality Control, Academics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Asia-Pacific Historic Review for Rat Model by Application - Research & Development , Production & Quality Control, Academics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Asia-Pacific 16-Year Perspective for Rat Model by Application - Percentage Breakdown of Value Sales for Research & Development , Production & Quality Control, Academics and Other Applications for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 188: Rest of World Recent Past, Current & Future Analysis for Rat Model by End-Use - Human and Veterinary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Rest of World Historic Review for Rat Model by End-Use - Human and Veterinary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Rest of World 16-Year Perspective for Rat Model by End-Use - Percentage Breakdown of Value Sales for Human and Veterinary for the Years 2014, 2024 & 2030
    • TABLE 191: Rest of World Recent Past, Current & Future Analysis for Rat Model by Rat Type - Inbred, Outbred, Knockout, Hybrid and Other Rat Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Rest of World Historic Review for Rat Model by Rat Type - Inbred, Outbred, Knockout, Hybrid and Other Rat Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Rest of World 16-Year Perspective for Rat Model by Rat Type - Percentage Breakdown of Value Sales for Inbred, Outbred, Knockout, Hybrid and Other Rat Types for the Years 2014, 2024 & 2030
    • TABLE 194: Rest of World Recent Past, Current & Future Analysis for Rat Model by Technology - CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of World Historic Review for Rat Model by Technology - CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of World 16-Year Perspective for Rat Model by Technology - Percentage Breakdown of Value Sales for CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 197: Rest of World Recent Past, Current & Future Analysis for Rat Model by Application - Research & Development , Production & Quality Control, Academics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of World Historic Review for Rat Model by Application - Research & Development , Production & Quality Control, Academics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of World 16-Year Perspective for Rat Model by Application - Percentage Breakdown of Value Sales for Research & Development , Production & Quality Control, Academics and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!